Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,108
archived clinical trials in
Lupus

Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Durham, NC
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Single Dose, Two-period, Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of AMG 811 in Subjects With Discoid Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Birmingham, AL
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
San Diego, CA
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
New Haven, CT
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Anderson, IN
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Anderson, IN
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Bronx, NY
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Allentown, PA
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/12/2012
Clinical Research Facility
mi
from
Houston, TX
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Ascending, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/12/2012
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Status: Enrolling
Updated:  7/20/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Photoprovocation Testing in Subjects With Cutaneous Lupus
Photoprovocation Testing in Subjects With Cutaneous Lupus
Status: Enrolling
Updated: 7/20/2012
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Status: Enrolling
Updated:  8/1/2012
Columbia University Medical Center, Division of Nephrology, Glomerular Center
mi
from
New York, NY
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Status: Enrolling
Updated: 8/1/2012
Columbia University Medical Center, Division of Nephrology, Glomerular Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Wallace Rheumatic Study Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Stanford Dermatology
mi
from
Redwood City, CA
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Stanford Dermatology
mi
from
Redwood City, CA
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Memorial Medical Group Clinical Research Institute
mi
from
South Bend, IN
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Memorial Medical Group Clinical Research Institute
mi
from
South Bend, IN
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
North Shore Long Island Health System
mi
from
Lake Success, NY
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
North Shore Long Island Health System
mi
from
Lake Success, NY
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Columbia University Medical Center
mi
from
New York, NY
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
University of Pennsylvania-Dermatology Research Office
mi
from
Philadelphia, PA
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
University of Pennsylvania-Dermatology Research Office
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Metroplex Clinical Research Center
mi
from
Northeast, TX
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Metroplex Clinical Research Center
mi
from
Northeast, TX
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
University of Texas Medical School in Houston
mi
from
Houston, TX
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
University of Texas Medical School in Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
University of Utah Department of Dermatology
mi
from
Salt Lake City, UT
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
University of Utah Department of Dermatology
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated:  8/17/2012
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of R333 6% Ointment Administered Topically to Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Patients With Active Cutaneous Discoid Lesions
Status: Enrolling
Updated: 8/17/2012
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
A Multi-center, Double-blind, Placebo-controlled, Proof-of-concept Study to Evaluate the Efficacy and Tolerability of KRP203 in Patients With Active Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  9/25/2012
Novartis Investigative Site
mi
from
Ann Arbor, MI
Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
A Multi-center, Double-blind, Placebo-controlled, Proof-of-concept Study to Evaluate the Efficacy and Tolerability of KRP203 in Patients With Active Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 9/25/2012
Novartis Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Hackensack University Medical Center
mi
from
Hackensack, NJ
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Morgan Stanley Children's Hospital of New York
mi
from
New York, NY
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Morgan Stanley Children's Hospital of New York
mi
from
New York, NY
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Columbus Children's Hospital
mi
from
Columbus, OH
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Columbus Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Children's Hospital of Oklahoma
mi
from
Oklahoma City, OK
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Children's Hospital of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated:  11/1/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Triptorelin for Ovary Protection in Childhood Onset Lupus
Status: Enrolling
Updated: 11/1/2012
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Clinical and Immune-modulating Effects of CC-10004 in Discoid Lupus Erythematosus
Status: Enrolling
Updated:  12/10/2012
New York University Tisch Hospital
mi
from
New York City, NY
Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Clinical and Immune-modulating Effects of CC-10004 in Discoid Lupus Erythematosus
Status: Enrolling
Updated: 12/10/2012
New York University Tisch Hospital
mi
from
New York City, NY
Click here to add this to my saved trials
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
Status: Enrolling
Updated:  12/26/2012
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis
Status: Enrolling
Updated: 12/26/2012
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus
A Single-site, Investigator Initiated Open-Label Trial of H.P. Acthar Gel (Repository Corticotropin Injection)an Adrenocorticotropic Hormone (ACTH) Analogue in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated:  1/30/2013
Justus J. Fiechtner, MD, PC
mi
from
Lansing, MI
Open-label Trial of Acthar Gel in Subjects With Moderate to Severe Active Systemic Lupus Erythematosus
A Single-site, Investigator Initiated Open-Label Trial of H.P. Acthar Gel (Repository Corticotropin Injection)an Adrenocorticotropic Hormone (ACTH) Analogue in Subjects With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)
Status: Enrolling
Updated: 1/30/2013
Justus J. Fiechtner, MD, PC
mi
from
Lansing, MI
Click here to add this to my saved trials
An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)
A Randomised, Placebo-controlled, Double-blind, Multiple-dose, Dose-escalation Trial Investigating the Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/24/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Long Beach, CA
An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)
A Randomised, Placebo-controlled, Double-blind, Multiple-dose, Dose-escalation Trial Investigating the Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/24/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)
A Randomised, Placebo-controlled, Double-blind, Multiple-dose, Dose-escalation Trial Investigating the Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated:  7/24/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Fort Worth, TX
An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)
A Randomised, Placebo-controlled, Double-blind, Multiple-dose, Dose-escalation Trial Investigating the Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus
Status: Enrolling
Updated: 7/24/2013
Novo Nordisk Clinical Trial Call Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Birmingham, AL
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Austin, TX
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated:  7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
A Randomized, Double-blind, Placebo-controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effect of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
Status: Enrolling
Updated: 7/31/2013
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials